Pharmacogenetic testing, which is used to classify how patients with major depressive disorder (MDD) metabolize medications, reduces adverse drug-gene interactions, new research shows. In a randomized ...

Learn about depression, its symptoms, causes, and treatment options. Get trusted information from NAMI to better understand ...

Most antidepressants are metabolized through the cytochrome P (CYP) 450 pathway; therefore, most drug metabolism genes on pharmacogenetic testing panels are related to CYP450 oxidase enzyme subunits.

Patients with first-episode MDD showed lower effective and functional connectivity between the anterior cingulate cortex and frontal regions.

An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...

Adding a daily fish oil supplement to psychotherapy showed no significant benefit over placebo for kids and teens with ...